Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma (Q33381844)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma |
scientific article |
Statements
1 reference
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma (English)
1 reference
Hagop Kantarjian
1 reference
Larry W Kwak
1 reference
Michael Wang
1 reference
Fredrick Hagemeister
1 reference
Peter McLaughlin
1 reference
Maria A Rodriguez
1 reference
Yuhong Zhou
1 reference
Jorge Romaguera
1 reference
1 November 2008
1 reference
1 reference
113
1 reference
10
1 reference
2734-2741
1 reference
Identifiers
1 reference
1 reference